Design Therapeutics Inc.

4.73
-0.13 (-2.67%)
At close: Mar 03, 2025, 12:45 PM

Design Therapeutics Income Statement

Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a 226.00 834.00
Cost of Revenue 537K 466K 129K 5K 1.65K
Gross Profit -537K -466K -129K -4.77K -820
Operating Income -78.19M -67.59M -35.83M -8.33M -1.91M
Interest Income n/a n/a n/a n/a n/a
Pretax Income -66.86M -63.31M -35.53M -8.28M -2.05M
Net Income -66.86M -58.62M -35.53M -8.28M -2.05M
Selling & General & Admin 21.13M 18.98M 11.05M 2.5M 1.09M
Research & Development 57.06M 48.61M 24.78M 6.06M 1.65M
Other Expenses n/a 4.29M 298K -226K -834K
Operating Expenses 78.19M 67.59M 35.83M 8.33M 1.91M
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 78.19M 67.59M 35.83M 8.33M 1.91M
Income Tax -1 -4.69M -107.56K -201.3K -1.91K
Shares Outstanding (Basic) 55.98M 55.71M 45.94M 27.19M 27.19M
Shares Outstanding (Diluted) 55.98M 55.71M 45.94M 27.19M 27.19M
EPS (Basic) -1.19 -1.05 -0.77 -0.3 -0.08
EPS (Diluted) -1.19 -1.05 -0.77 -0.3 -0.08
EBITDA -66.33M -62.84M -35.7M -8.32M -139K
Depreciation & Amortization 537K 466K 129K 5K 1.91M